Previous studies identified that immune cell infiltration played a role in the survival time of patients,[24] and GSEA results showed that CHRDL1 enriched in T and B cell receptor signaling pathways, which were associated with the immune system, so a pan-cancer analysis of various immune cells was performed. The gene discussed is CHRDL1; the disease is cancer.